Conavi Medical Corp. (CNVIF)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USDTTM unavailable| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 21 | 20 | 0 | 18 | 2 | 5 | - | 4 |
| Operating profit | $m | -8 | - | ||||||
| Net profit | $m | -24 | -15 | -41 | 7 | -32 | -11 | - | -7 |
| EPS reported | $ | -0.19 | - | ||||||
| Operating cashflow per share | $ | -0.22 | - | ||||||
| Capex per share | $ | 0.00 | - | ||||||
| FCF per share | $ | -0.23 | - | ||||||
| Free cash flow | $m | -13 | - | ||||||
| Net debt | $m | 9 | - | ||||||
| Book value equity | $m | -9 | - | ||||||
| Book value per share | $ | -0.16 | - | ||||||
| Number of shares | m | 57.51 | - | ||||||
| DPS (TTM paid) | $ | 0.00 | - |
Financial summary
Financials in USDTTM unavailable| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | -2.91 | - | ||||||
| P/S LTM | x | 5.76 | - | ||||||
| P/FCF LTM | x | -2.09 | - | ||||||
| EV/EBITDA LTM | x | -8.99 | - | ||||||
| EV/Sales LTM | x | 7.90 | - | ||||||
| Earnings Yield LTM | % | -39.07% | - | ||||||
| FCF Yield | % | -47.94% | - | ||||||
| Quality | |||||||||
| ROE | % | +113.79% | - | ||||||
| ROIC | % | -1.71% | - | ||||||
| Operating margin | % | -1.60% | - | ||||||
| Gross margin | % | +74.70% | - | ||||||
| FCF/Sales | % | -275.96% | - | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +194.90% | - | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | - | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | - | ||||||
| FCF/Debt | x | -0.91 | - | ||||||
| Net Debt/EBITDA | x | -2.44 | - | ||||||
| EBIT/Net interest | x | -1.25 | - | ||||||
| Net debt/market cap | % | +48.73% | - | ||||||
| Net debt/Equity | x | -0.97 | - | ||||||
| Gross debt/equity | x | -1.54 | - | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Conavi Medical Corp. is a medical technology firm that specializes in developing, manufacturing, and commercializing advanced imaging solutions. These innovations are specifically designed to provide guidance during minimally invasive cardiovascular procedures. A notable product is the Novasight Hybrid System, which uniquely combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single platform. This enables clinicians to obtain simultaneous and precisely co-registered images of the coronary arteries. Conavi Medical Corp. is headquartered in Toronto, Canada.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Conavi Medical Corp. is a medical technology firm that specializes in developing, manufacturing, and commercializing advanced imaging solutions. These innovations are specifically designed to provide guidance during minimally invasive cardiovascular procedures. A notable product is the Novasight Hybrid System, which uniquely combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single platform. This enables clinicians to obtain simultaneous and precisely co-registered images of the coronary arteries. Conavi Medical Corp. is headquartered in Toronto, Canada.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free